{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T11:52:39Z","timestamp":1769082759599,"version":"3.49.0"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":2011,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T00:00:00Z","timestamp":1592352000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>One prevalent comorbidity of chronic heart failure (CHF) is chronic kidney disease(CKD). Hyperkalemia is associated with both CHF and CKD, which often leads to withdrawal of heart failure medications in clinical praxis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>A patient is presented who suffered from acute kidney injury with pre-existing CKD as heart failure comorbidity and a history of hyperkalemia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This case shows that potassium levels remained stable in acute kidney injury under ongoing heart failure medications, including an MRA, with the use of the potassium binder patiromer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.12711","type":"journal-article","created":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T10:14:08Z","timestamp":1592388848000},"page":"3161-3164","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Management of Hyperkalaemia in Acute Kidney Injury in a Heart Failure Patient with Patiromer"],"prefix":"10.1093","volume":"7","author":[{"given":"Jonathan","family":"Slawik*","sequence":"first","affiliation":[{"name":"Klinik f\u00fcr Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universit\u00e4tsklinikum des Saarlandes, Universit\u00e4t des Saarlandes , Kirrberger Stra\u00dfe 100, 66421, Homburg, Saar ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliane","family":"Dederer","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universit\u00e4tsklinikum des Saarlandes, Universit\u00e4t des Saarlandes , Kirrberger Stra\u00dfe 100, 66421, Homburg, Saar ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Kindermann","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universit\u00e4tsklinikum des Saarlandes, Universit\u00e4t des Saarlandes , Kirrberger Stra\u00dfe 100, 66421, Homburg, Saar ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"B\u00f6hm","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universit\u00e4tsklinikum des Saarlandes, Universit\u00e4t des Saarlandes , Kirrberger Stra\u00dfe 100, 66421, Homburg, Saar ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,6,17]]},"reference":[{"key":"2026012114070310900_ehf212711-bib-0001","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00041552-200403000-00004","article-title":"The association between congestive heart failure and chronic renal disease","volume":"13","author":"Silverberg","year":"2004","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"2026012114070310900_ehf212711-bib-0002","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1253\/circj.CJ-09-0062","article-title":"Chronic kidney disease as an independent risk for long-term adverse outcomes in patients hospitalized with heart failure in Japan: Report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD)","volume":"73","author":"Hamaguchi","year":"2009","journal-title":"Circ J"},{"key":"2026012114070310900_ehf212711-bib-0003","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1253\/circj.CJ-10-0444","article-title":"Heart failure, chronic kidney disease, and biomarkers\u2014an integrated viewpoint","volume":"74","author":"Iwanaga","year":"2010","journal-title":"Circ J"},{"key":"2026012114070310900_ehf212711-bib-0004","first-page":"357","article-title":"Hyperkalemia associated with spironolactone therapy","volume":"51","author":"Dolovich","year":"2005","journal-title":"Can Fam Physician"},{"key":"2026012114070310900_ehf212711-bib-0005","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1038\/ki.2015.270","article-title":"Patiromer induces rapid and sustained potassium lowering in patients with chronic kidney disease and hyperkalemia","volume":"88","author":"Bushinsky","year":"2015","journal-title":"Kidney Int"},{"key":"2026012114070310900_ehf212711-bib-0006","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/ejhf.300","article-title":"Maintenance of serum potassium with sodium zirconium cyclosilicate (ZS-9) in heart failure patients: results from a phase 3 randomized, double-blind, placebo-controlled trial","volume":"17","author":"Anker","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"2026012114070310900_ehf212711-bib-0007","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1093\/eurheartj\/ehq502","article-title":"PEARL-HF Investigators. Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial","volume":"32","author":"Pitt","year":"2011","journal-title":"Eur Heart J"},{"key":"2026012114070310900_ehf212711-bib-0008","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"2026012114070310900_ehf212711-bib-0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.krcp.2016.02.001","article-title":"Changes in urinary potassium excretion in patients with chronic kidney disease","volume":"35","author":"Ueda","year":"2016","journal-title":"Kidney Res Clin Pract"},{"key":"2026012114070310900_ehf212711-bib-0010","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1093\/eurheartj\/ehl507","article-title":"Prognostic value of cystatin C in acute heart failure in relation to other markers of renal function and NT-proBNP","volume":"28","author":"Lassus","year":"2007","journal-title":"Eur Heart J"},{"key":"2026012114070310900_ehf212711-bib-0011","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1056\/NEJMoa040135","article-title":"Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study","volume":"351","author":"Juurlink","year":"2004","journal-title":"N Engl J Med"},{"key":"2026012114070310900_ehf212711-bib-0012","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1053\/j.ajkd.2017.12.006","article-title":"Management of heart failure in advancing CKD: core curriculum 2018","volume":"72","author":"House","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"2026012114070310900_ehf212711-bib-0013","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ahj.2017.03.011","article-title":"True rate of mineralocorticoid receptor antagonists-related hyperkalemia in placebo-controlled trials: a meta-analysis","volume":"188","author":"Vukadinovi\u0107","year":"2017","journal-title":"Am Heart J"},{"key":"2026012114070310900_ehf212711-bib-0014","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1093\/eurheartj\/ehx537","article-title":"Serum potassium in patients with chronic heart failure: once we make a U-turn where should we go?","volume":"38","author":"Pitt","year":"2017","journal-title":"Eur Heart J"},{"key":"2026012114070310900_ehf212711-bib-0015","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026012114070310900_ehf212711-bib-0016","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/ehjcvp\/pvy015","article-title":"Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology","volume":"4","author":"Rosano","year":"2018","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2026012114070310900_ehf212711-bib-0017","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/jama.2015.7446","article-title":"Effect of patiromer on serum potassium level in patients with hyperkalemia and diabetic kidney disease: The AMETHYST-DN Randomized Clinical Trial","volume":"314","author":"Bakris","year":"2015","journal-title":"JAMA"},{"key":"2026012114070310900_ehf212711-bib-0018","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1410853","article-title":"Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors","volume":"372","author":"Weir","year":"2015","journal-title":"N Engl J Med"},{"key":"2026012114070310900_ehf212711-bib-0019","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1093\/eurheartj\/ehq502","article-title":"Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial","volume":"32","author":"Pitt","year":"2011","journal-title":"Eur Heart J"},{"key":"2026012114070310900_ehf212711-bib-0020","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1410853","article-title":"Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors","volume":"372","author":"Weir","year":"2015","journal-title":"N Engl J Med"},{"key":"2026012114070310900_ehf212711-bib-0021","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/ejhf.402","article-title":"Effect of patiromer on reducing serum potassium and preventing recurrent hyperkalaemia in patients with heart failure and chronic kidney disease on RAAS inhibitors","volume":"17","author":"Pitt","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"2026012114070310900_ehf212711-bib-0022","doi-asserted-by":"crossref","first-page":"115","DOI":"10.15420\/ecr.2014.9.2.115","article-title":"Hypertension in chronic kidney disease\u2014role of arterial calcification and impact on treatment","volume":"9","author":"Phan","year":"2014","journal-title":"Eur Cardiol"},{"key":"2026012114070310900_ehf212711-bib-0023","first-page":"1803","article-title":"Hypertension and heart failure","volume":"124","author":"Rodeheffer","year":"2011","journal-title":"ALLHAT Imperative Circ"},{"key":"2026012114070310900_ehf212711-bib-0024","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"key":"2026012114070310900_ehf212711-bib-0025","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/S0140-6736(19)32135-X","article-title":"Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomized, double-blind, placebo-controlled trial","author":"Agarwal","year":"2019","journal-title":"Lancet"},{"key":"2026012114070310900_ehf212711-bib-0026","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/ejhf.1402","article-title":"Reduced loop diuretic use in patients taking sacubitril\/valsartan compared with enalapril: the PARADIGM-HF trial","volume":"21","author":"Vardeny","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"2026012114070310900_ehf212711-bib-0027","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/ejhf.1465","article-title":"Real-world treatment patterns of sacubitril\/valsartan: a longitudinal cohort study in Germany","volume":"21","author":"Wachter","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"2026012114070310900_ehf212711-bib-0028","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1517\/13543784.13.6.643","article-title":"Recent advances in natriuretic peptides in congestive heart failure","volume":"13","author":"Boerrigter","year":"2004","journal-title":"Expert Opin Investig Drugs"},{"key":"2026012114070310900_ehf212711-bib-0029","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.2174\/1381612811319170009","article-title":"Angiotensin II blockade and renal protection","volume":"19","author":"Kobori","year":"2013","journal-title":"Curr Pharm Des"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fehf2.12711","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ehf2.12711","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ehf2.12711","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/7\/5\/3161\/65807059\/eschf_7_5_3161.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/7\/5\/3161\/65807059\/eschf_7_5_3161.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:07:39Z","timestamp":1769022459000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/7\/5\/3161\/8372148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,17]]},"references-count":29,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,6,17]]},"published-print":{"date-parts":[[2020,10,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.12711","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,10]]},"published":{"date-parts":[[2020,6,17]]},"assertion":[{"value":"2020-01-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}